FdaApplication
NDA 209092
Identifiers
- fda_app_no: NDA209092
Properties
| Property | Value |
|---|---|
| applicant_name | NOVARTIS PHARMACEUTICALS CORP |
| application_type | NDA |
| approval_date | 2017-03-13 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| KISQALI | RIBOCICLIB SUCCINATE | EQ 200MG BASE | TABLET;ORAL |
1 product